Risk factor | Overall Survival | Progression-Free Survival | |||
---|---|---|---|---|---|
HR (95 % CI) | p-value | HR (95 % CI) | p-value | ||
KLK6 | |||||
low vs. high1 | 2.793 (1.498–5.209) | 0.001 | 2.236 (1.291–3.873) | 0.004 | |
Age [years] | |||||
<58.621 vs. ≥58.62 | 1.588 (0.892–2.825) | 0.116 | 1.359 (0.811–2.277) | 0.244 | |
Gender | |||||
male1 vs. female | 0.571 (0.268–1.219) | 0.148 | 0.567 (0.281–1.143) | 0.112 | |
Clinical stage | |||||
I/II1 vs. III/IV | 2.333 (0.892–6.104) | 0.084 | 1.621 (0.724–3.629) | 0.240 | |
Pathological grade | |||||
G1/21 vs. G3 | 0.811 (0.431–1.527) | 0.517 | 1.135 (0.648–1.987) | 0.658 | |
smoking | |||||
non-smoker1 vs. smoker2 | 1.701 (0.602–4.808) | 0.317 | 2.831 (1.013–7.912) | 0.047 | |
Alcohol consumption | |||||
non-drinker1 vs. drinker3 | 0.911 (0.343–2.418) | 0.852 | 1.056 (0.440–2.535) | 0.903 |